Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
European Journal of Clinical Pharmacology|December 18, 1978
Effect of delayed administration of activated charcoal on nortriptyline absorptionS Dawling, P Crome, R BraithwaiteClinical Pharmacokinetics|July 1, 1980
Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteersS Dawling, P Crome, R BraithwaiteClinical Pharmacokinetics|October 1, 1989
Clinical pharmacokinetic considerations in the elderly. An updateS Dawling, P CromeHuman Toxicology|April 1, 1983
In vitro and in vivo evaluation of two preparations of activated charcoal as adsorbents of aspirinS Dawling, S Chand, R A Braithwaite, et al.The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1981
Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg doseS Dawling, P Crome, E J Heyer, et al.Human Toxicology|April 1, 1983
Activated charcoal in tricyclic antidepressant poisoning: pilot controlled clinical trialP Crome, R Adams, C Ali, et al.Clinical Pharmacology and Therapeutics|March 1, 1978
High plasma nortriptyline levels in the treatment of depression. IS Montgomery, R Braithwaite, S Dawling, et al.European Journal of Clinical Pharmacology|January 1, 1981
Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysisK Lynn, R Braithwaite, S Dawling, et al.Clinical Pharmacology and Therapeutics|September 1, 1982
Nortriptyline metabolism in chronic renal failure: metabolite eliminationS Dawling, K Lynn, R Rosser, et al.Lancet (London, England)|December 10, 1977
Effect of activated charcoal on absorption of nortriptylineP Crome, S Dawling, R A Braithwaite, et al.Pageof 17